Q1 EPS Estimate for Healthpeak Properties Lowered by Analyst

Healthpeak Properties, Inc. (NYSE:DOC) – Equities researchers at Wedbush dropped their Q1 2025 EPS estimates for shares of Healthpeak Properties in a note issued to investors on Thursday, December 19th. Wedbush analyst R. Anderson now expects that the real estate investment trust will post earnings of $0.46 per share for the quarter, down from their previous forecast of $0.47. The consensus estimate for Healthpeak Properties’ current full-year earnings is $1.80 per share. Wedbush also issued estimates for Healthpeak Properties’ Q2 2025 earnings at $0.46 EPS, Q3 2025 earnings at $0.47 EPS, Q4 2025 earnings at $0.48 EPS and FY2025 earnings at $1.86 EPS.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The business had revenue of $700.40 million during the quarter, compared to analysts’ expectations of $682.51 million. During the same period in the prior year, the company posted $0.45 EPS. The company’s revenue for the quarter was up 25.9% on a year-over-year basis.

A number of other research analysts also recently commented on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and increased their price objective for the company from $20.00 to $28.00 in a research note on Monday, October 21st. Wells Fargo & Company reduced their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. Mizuho lowered their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Evercore ISI upped their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, September 16th. Finally, Scotiabank lifted their target price on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and an average price target of $23.62.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $20.12 on Monday. Healthpeak Properties has a 52 week low of $16.01 and a 52 week high of $23.26. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The stock has a market cap of $14.07 billion, a P/E ratio of 42.81, a price-to-earnings-growth ratio of 2.37 and a beta of 1.13. The stock has a 50 day moving average of $21.80 and a 200-day moving average of $21.40.

Healthpeak Properties Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $1.20 annualized dividend and a dividend yield of 5.96%. Healthpeak Properties’s dividend payout ratio is currently 255.32%.

Institutional Trading of Healthpeak Properties

A number of large investors have recently modified their holdings of the company. State Street Corp bought a new position in Healthpeak Properties in the 3rd quarter worth about $1,093,576,000. Geode Capital Management LLC acquired a new position in shares of Healthpeak Properties during the third quarter worth approximately $403,898,000. Charles Schwab Investment Management Inc. bought a new position in Healthpeak Properties in the 3rd quarter worth approximately $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Healthpeak Properties in the 3rd quarter valued at approximately $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. bought a new stake in Healthpeak Properties during the 3rd quarter valued at $102,615,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.